[Form 4] Ameren Corporation Insider Trading Activity
Transaction summary: Michael L. Moehn, Sr Executive VP & CFO of Ameren Corporation (AEE), reported a sale of 6,500 shares of Ameren common stock on 08/01/2025 at $102.54 per share. Following the reported transaction, Mr. Moehn beneficially owns 204,879 shares directly. He also holds 5,147 share equivalents indirectly in the Ameren Savings Investment Plan unitized stock fund as of 07/31/2025.
Filing notes: The Form 4 was dated and signed by Jonathan T. Shade as attorney-in-fact on 08/05/2025. The filing states that the reported direct total includes 611 accrued dividend equivalents acquired in Q2 2025 pursuant to dividend reinvestment of restricted stock units under the issuer's 2022 Omnibus Incentive Compensation Plan. No derivative transactions were reported on this form.
- Timely Section 16 disclosure with transaction date, amount, and price clearly reported
- Separation of direct and indirect holdings and footnote explanations increase transparency
- Officer sale of 6,500 shares reduces reported direct holdings
- No commentary in the filing on rationale or planned trading arrangements
Insights
TL;DR Officer sale of 6,500 AEE shares disclosed; holdings remain materially concentrated at 204,879 direct shares.
The Form 4 reports a sale of 6,500 Ameren (AEE) common shares on 08/01/2025 at $102.54. Post-transaction direct beneficial ownership is reported as 204,879 shares. The filing also documents 5,147 indirect share equivalents in the Ameren Savings Investment Plan as of 07/31/2025 and notes 611 accrued dividend equivalents added in Q2 2025 tied to restricted stock units. No options, warrants, or other derivatives appear in Table II. This is a routine Section 16 disclosure of an officer transaction; the filing supplies concrete holdings and transaction price for modeling insider activity.
TL;DR Timely Form 4 filing by CFO documents insider sale and ancillary plan holdings; disclosure meets Section 16 requirements.
The report identifies Michael L. Moehn as the reporting person (Sr Executive VP & CFO) and indicates the Form 4 was executed by an attorney-in-fact on 08/05/2025. The filing separates direct vs indirect holdings (204,879 direct; 5,147 indirect via the company savings plan) and includes explanatory footnotes regarding unitized fund balances and dividend reinvestment of RSUs. From a governance perspective, the disclosure is precise: transaction date, count, and price are specified and no amendments or Schedule II derivative entries are shown. This supports transparency around executive equity activity.